Prevalenc of Acquired cyctic kidney disease and its relation with anemia in ESRD patients at Hemodialysis center
Abstract
Background. Acquired renal cystic disease is an important complication of end-stage chronic kidney disease (ESRD) that is not widely studied and has a poorly defined clinical course.
The development of AKI is often asymptomatic, and the most serious complications are retroperitoneal hemorrhage and renal cell carcinoma.
The aim of this study was to investigate the prevalence of acquired CKD in these patients and its relationship with anemia, duration of hemodialysis therapy, and arterial hypertension.
Methods: : The study included 150 patients who underwent kidney ultrasound with end-stage chronic kidney disease at the hemodialysis department at Tishreen University Hospital from 2022-2024
Results: The incidence of Acquired renal cystic disease was 21.3% during the first year of evaluation and increased to 36% a year later at re-evaluation.
Arterial hypertension was the most common comorbidity in the study sample (72%), followed by diabetes mellitus (29.3%).
The most common reason for the need for hemodialysis treatment was hypertension (66.7%), followed by diabetes mellitus (28.7%).
The category of patients treated with hemodialysis less than 3 years old was the highest in the studied research sample with 60.7%.
50.7% of patients in the study sample had at least one cyst in at least one kidney.
59.3% of patients in the study sample had moderate anemia (7-10 g/dL).
The age group older than 40 years was the highest percentage of the research sample, amounting to 73.3%.
Conclusion: Acquired renal cystic disease is a common complication in patients with end-stage chronic kidney disease treated with hemodialysis.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
